About Omlog


  • omlog is a way for us at Sankara Nethralaya – a 25-year old eye institution in Chennai, India – to keep in constant touch with you, our friends and well-wishers around the world. We hope that you will help us spread the word about our activities and accomplishments in alleviating the problem of blindness that afflicts so many poor people in India. Your continued support, in any form, is greatly appreciated!

    Please help us spread the word about Sankara Nethralaya, tell a friend about us.

SUBSCRIBE


  • Enter your Email


    Powered by FeedBlitz

    Or, choose one of your favorite RSS readers from this list


    Subscribe in NewsGator Online
    Subscribe in Rojo
    Add omlog to Newsburst from CNET News.com
    Add to Google

    Add to My AOL
    Subscribe in FeedLounge
    Subscribe in Bloglines

SiteLog

« Mebiol Gel Applications | Main | Eye Camp For Journalists »

Molecular Medicine To The Rescue

Dr. Colins Barnstable, D. Phil, Yale University School of Medicine, USA and Joyce Tombran Tink, Ph.D., University of Missouri, Kansas, visited Sankara Nethralaya on April 4, 2005. They were taken to all the research labs and they spent little longer time in the departments where they had discussions on areas of mutual interests. They provided us with a soft copy of all their recent publications and have volunteered to help us with the data base information on the origin of the 88KD protein.

Later in the evening Dr. Colin Barnstable gave a lecture on "Growth factors and Neuroprotection in the retina" and Dr. Joyce Tombran Tink gave a lecture on "Control of cell death and cell survival in retinal diseases by PEDF," which was very informative as it elaborated on the therapeutic prospects of PEDF as an antiangiogenic and neuroprotective agent. A therapeutic intervention based on molecular medicine seems to be gaining momentum.

Comments

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.

This weblog only allows comments from registered users. To comment, please Sign In.